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a  b  s  t  r  a  c  t
Paragangliomas  are  rare  neoplasms  arising  from  cells  of  the  primitive  neural  crest.  These  tumours  are
often  difﬁcult  to diagnose  and treat.  We  report  a case  of  a 42  year  old  female  presenting  with  abdominal
pain  who  had  a retroperitoneal  tumour  situated  at the  aortic  bifurcation.  Serum  catecholamine  lev-ccepted 8 November 2015
vailable online 12 November 2015
eywords:
araganglioma
els  were  normal.  Complete  resection  of  the  tumour  was  performed.  The  histological  examination  and
immunohistochemical  analyses  concluded  the  diagnosis  of  an  organ  of  Zuckerkandl  paraganglioma.
© 2015  The  Authors.  Published  by Elsevier  Ltd.  on  behalf  of  IJS Publishing  Group  Ltd.  This is  an  open
access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).rgan of Zuckerkandl
euroendocrine tumour
. Introduction
Paragangliomas are rare neuroendocrine tumours arising from a
idely dispersed collection of specialised neural crest cells [1]. The
drenal medullae represent the largest collection of paraganglionic
issue; tumours derived from them occur much more frequently
han in extra-adrenal locations. It has been estimated that 10%
f paragangliomas arise outside the adrenal glands [2]. The most
ommon site of extra-adrenal occurrence is intra-abdominal, usu-
lly within the para-aortic and peri-nephric spaces [3]. Other rarer
ites include the thorax, skull base and neck. Paragangliomas may
e functional and result in symptoms of excess catecholamine pro-
uction. Approximately 10–15% of such tumours is non-functional,
nd in another 10% hormone activity is not manifest clinically. They
re often locally invasive and associated with a high incidence of
ocal recurrence [4].
Non-functional paragangliomas pose a signiﬁcant diagnostic
hallenge. In the absence of typical symptoms of catecholamine
xcess, the diagnosis of such tumours is often delayed [5]. In
his report, the authors describe a new case of non-functional
etroperitoneal paraganglioma discovered during investigation of
bdominal pain.Abbreviations: CT, computed tomography; NSE, neuron-speciﬁc enolase; MIBG,
etaiodobenzylguanidine.
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E-mail address: ecgannan@yahoo.com.au (E. Gannan).
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210-2612/© 2015 The Authors. Published by Elsevier Ltd. on behalf of IJS Publishing Gro
http://creativecommons.org/licenses/by-nc-nd/4.0/).2. Presentation of case
A 42 year old female was  referred with vague abdominal pain of
several years duration. She had a history of hypertension and her
blood pressure was 135/95 mmHg  at the time of admission, how-
ever she denied symptoms of catecholamine excess. She was taking
no regular medications. There was  no family history of illness. The
physical examination was  unremarkable with no palpable abdomi-
nal mass present. Abdominal ultrasonography showed an abnormal
soft tissue mass anterior to the aortic bifurcation, initially thought
to represent lymphadenopathy. Abdominal computed tomography
(CT) showed a solitary well-deﬁned heterogeneous mass centred
level with the L5 vertebral body slightly to the left of midline, imme-
diately anterior to the two common iliac arteries (Fig. 1) which was
more consistent with paraganglioma. CT chest showed no intra-
thoracic malignancy. Serum chromogranin A level was  elevated
at 276 ug/L (normal range 27–94 ug/L). The lesion was  completely
resected through a midline laparotomy incision. On macroscopic
examination the mass measured 5.5 × 4.0 × 2.5 cm and was encap-
sulated with a lobulated, variegated orange/brown cut surface and
central areas of hemorrhage (Fig. 2).
Histological examination identiﬁed a highly cellular, multin-
odular encapsulated tumour with a vascular framework containing
many dilated and congested blood vessels (Fig. 3). The tumour
was composed of compact nests of varying size in alveolar pat-
tern. Two  cell populations were noted within the tumour: larger
epithelioid type cells with ill-deﬁned granular cytoplasm and cells
with small ovoid to polygonal monomorphic nuclei with granular
chromatic pattern. The other cells were smaller, somewhat similar
with scant cytoplasm. In places, zellballen pattern of paraganglioma
was apparent. Diffuse sheets of tumour cells were also present. In
up Ltd. This is an open access article under the CC BY-NC-ND license
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Fig. 1. CT Scan: organ of Zuckerkandl paraganglioma.
Fig. 2. Operative photo: organ of Zuckerkandl paraganglioma.
Fig. 3. Haematoxylin and eosin stain: paraganglioma.Fig. 4. Immunohistochemistry: cells expressing chromogranin.
one area, larger cells of epithelioid type, with eosinophilic gran-
ular cytoplasm, arranged in strands showed variation in nuclear
size and shape with hyperchromasia. Occasional multinucleate
giant cells were also seen. The tumour inﬁltrated the capsule and
ﬁbro-collagenous bands. Probable lymphovascular permeation was
present. Immunohistochemical staining of the tumour showed that
it strongly expressed chromogranin (Fig. 4), neuron-speciﬁc eno-
lase (NSE) and synaptophysin. These ﬁndings led to a histological
diagnosis of retroperitoneal paraganglioma.
Post-operative 24-hour urine catecholamine studies and plasma
metanephrines were negative. Scintigraphy with 123-I labeled
metaiodobenzylguanidine (MIBG) was also negative. There were
no complications over 6 months of follow up.
3. Discussion
Paragangliomas are rare tumours arising from sympathetic and
parasympathetic paraganglia, which are derived from the neu-
ral crest cells. Those arising from the adrenal medulla are named
phaeochromocytoma and comprise approximately 80% of these
tumours. Extra-adrenal paragangliomas are found arising from
chromafﬁn tissue along the autonomic nervous system and can thus
be found in the head, neck, thorax, abdomen and pelvis. The most
common site of sympathetic paragangliomas is in the abdomen,
usually located in the organ of Zuckerkandl at the aortic bifurcation,
consistent with the distribution of paraganglia ﬁrst characterized
in the human fetus by Zuckerkandl in 1901 [6,7].
The median age of diagnosis for retroperitoneal paragangliomas
is 37–43 years and the incidence is similar between men  and
women [1,8,9]. A large proportion of paragangliomas are related
to disease-causing mutations or hereditary syndromes such as Von
Hippel–Lindau (VHL) gene mutations, multiple endocrine neopla-
sia type 2 (MEN2), neuroﬁbromatosis type 1 (NF1), the Carney triad
and gene mutations of the subunits of succinate dehydrogenase
(SDH) [10,11].
Patients with functional paragangliomas that produce cate-
cholamines may  experience hypertension, ﬂushing, tachycardia,
palpitations, anxiety, headache and/or profuse diaphoresis [4,5,12].
Those with non-functioning retroperitoneal paragangliomas may
be diagnosed incidentally or present with compressive symptoms
such as abdominal pain that may  be associated with nausea, vom-
iting, abdominal distension and weight loss [4,13]. Non-functional
retroperitoneal paragangliomas have also been reported to present
atypically with chest pain or paralytic ileus [14,15]. The diverse
range of presentations often makes the clinical diagnosis of these
tumours difﬁcult.
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Serum levels of chromogranin A, NSE or vimentin are elevated
ith most of the neuroendocrine tumours and are helpful to dif-
erentiate them from non-neuroendocrine tumours. On the basis
f endocrine symptoms, neuroendocrine tumours can be differen-
iated by using hormonal assay in blood or urine. Ultrasound may  be
sed as a ﬁrst-line investigation however CT and MRI have higher
ensitivity. Paragangliomas may  show central necrosis or haem-
rrhage, calciﬁcation and enhancement. Functional imaging with
IBG scintigraphy may  be used for better localisation of extra-
drenal disease or metastatic sites. Angiography may  be useful
n revealing vascular invasion or in demonstrating small metas-
ases [16]. Ultimately although imaging techniques are helpful, the
iagnosis of paragangliomas can only be conﬁrmed with careful
istological and immunohistochemical evaluation [17,18].
Due to the malignant potential of paragangliomas, surgical exci-
ion is the preferred management. Resection is often challenging as
hese highly vascular tumours are frequently located near multiple
ital blood vessels. If a tumour is felt to be unresectable, attempts
o reduce its size using chemotherapy, radiation therapy or emboli-
ation may  be indicated because resection offers the only chance of
ure [19]. Radiotherapy may  also be used for inoperable tumours
r for palliation. Radionucleotides may  be the indicated therapy for
umours exhibiting uptake on diagnostic scan. Inoperable paragan-
liomas can be treated with octreotide [20].
Histologically paragangliomas are diagnosed by their highly
ascular appearance, with chief cells and sustenacular cells
rranged in clusters called zellballen. Chief cells are often positive
or neuroendocrine markers (synaptophysin, NSE, chromogranin)
n immunohistochemistry, while sustenacular cells are positive
or S-100 protein [5]. Malignancy cannot be reliably diag-
osed histologically and is often diagnosed based on presence
f metastases. Approximately 20–42% of extra-adrenal sympa-
hetic paragangliomas metastasise, compared to only 2–10% of
haeochromocytomas. Sites of metastasis include lymph nodes,
one, liver and lung. Metastatic lesions have a poor prognosis, with
 reported 5-year survival rate of 36% [4].
. Conclusion
Paragangliomas of the retroperitoneum are a rare group of
umours with malignant potential that cause considerable difﬁ-
ulty both in diagnosis and treatment. Our case highlights the
mportance of including the extra-adrenal paraganglioma in the
ifferential diagnosis of retroperitoneal tumours. Advances in
enetic testing and discovery of new molecular markers are con-
ributing to increased understanding of paragangliomas, however
t present there is no way to deﬁnitively predict metastatic risk.
s recurrence and metastasis are common, lifelong follow-up is
equired.
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